AT354589T

Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Abstract

Cyclopeptide, chosen from the following compounds: P11: cyclo (DPhe-Pro-Gln-lle-Met-Arg-lle-Lys-Pro-His-Gln-Gly-Gln-His-lle-Gly-Glu) SEQ ID NO: 5 P16: cyclo (Arg-lle-Lys-Pro-His-Gln-Gly) SEQ ID NO: 8 P17: cyclo (Pro-Arg-lle-Lys-Pro-His-Gln-Gly) SEQ ID NO: 9 P19 : cyclo (Gln-lle-Met-Arg-Glu-Gly-lle-Lys-Pro-His-Gln-Gly-Gln-His-lle) SEQ ID NO: 10 P20: cyclo (DPhe-Pro-Gln-lle- Met-Arg-lle-Lys-Pro-His-Gln-Gly-Gln-His-Gly lle) SEQ ID NO: 11 P23: cyclo (-DTyr-Pro-Arg-lle-Lys-Pro-His-Gln) SEQ ID NO: 13 P24: cyclo (Gly-Arg-lle-Lys-Pro-His) SEQ ID NO: 25

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

24 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
0012654FranceA

Members24

Family members, oldest first
DocumentOfficeKind
FR2814744A1FranceA1
CA2424506A1CanadaA1
WO0228895A2World Intellectual Property Organization (WIPO)A2
AU9394801AAustraliaA
WO0228895A3World Intellectual Property Organization (WIPO)A3
FR2814744B1FranceB1
NO20031377D0NorwayD0
NO20031377LNorwayL
EP1328546A2European Patent Office (EPO)A2
IL155117D0IsraelD0
JP2004510784AJapanA
US2004092434A1United States of AmericaA1
NZ525069ANew ZealandA
RU2249599C2Russian FederationC2
AU2001293948B2AustraliaB2
EP1328546B1European Patent Office (EPO)B1
AT354589TThis recordAustriaT
US7199100B2United States of AmericaB2
DE60126802D1GermanyD1
DK1328546T3DenmarkT3
ES2282293T3SpainT3
DE60126802T2GermanyT2
JP4303958B2JapanB2
USRE44022EUnited States of AmericaE